SYNLOGIC, INC. Increase (Decrease) in Other Noncurrent Liabilities
SYNLOGIC, INC. (SYBX) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2023-03-29
- SYNLOGIC, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-12-31 was -$45.00K.
- SYNLOGIC, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-09-30 was $94.00K.
- SYNLOGIC, INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $0.00.
- SYNLOGIC, INC. increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$131.00K, a 200.00% decline from fiscal 2020.
- SYNLOGIC, INC. increase (decrease) in other noncurrent liabilities for fiscal 2020 was $131.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-29 | |||
| 2021-12-31 | -$131.00K 10-K · filed 2023-03-29 | |||
| 2020-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $49.00K derived: sum of 2 quarters · filed 2022-03-17 | $131.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $176.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $82.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |